Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?

Volume: 31, Issue: 2, Pages: 150 - 164
Published: Feb 1, 2020
Abstract
Individuals with type 1 diabetes (T1D) frequently fail to achieve glycemic goals and have excess cardiovascular risk and premature death. Adjunctive agents may play a role in reducing morbidity, mortality, and the adverse sequelae of insulin treatment. A surge in type 2 diabetes drug development has revealed agents with benefits beyond glucose lowering, including cardiovascular risk reduction. Could these benefits translate to T1D? Specific...
Paper Details
Title
Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?
Published Date
Feb 1, 2020
Volume
31
Issue
2
Pages
150 - 164
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.